Finepoint Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17M | Sell |
|
|||||
|
2024
Q4 | $24.3M | Buy |
|
|||||
|
2024
Q3 | $19.6M | Hold |
|
|||||
|
2024
Q2 | $17.1M | Buy |
|
|||||
|
2024
Q1 | $18.1M | Sell |
|
|||||
|
2023
Q4 | $62.7K | Buy |
|
|||||
|
2023
Q3 | $18.9M | Buy |
|
|||||
|
2023
Q2 | $15.4M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $3.77M | Buy |
|
|||||
|
2021
Q2 | $3.62M | Buy |
|